3 Results 3.1 Renal Impairment Study A total of 199 participants were screened and 33 were exposed to cagrilintide (full analysis set and safety analysis set: normal renal function, n = 14
Owing to their large molecular size and structural complexity, biologics often exhibit poor stability, requiring stringent storage and handling conditions to prevent degradation
With injectable and oral GLP-1 options now in development and approved, Novo Nordisk continues to build a broad obesity treatment portfolio aimed at long-term disease management rather than short-term weight loss alone
Lifestyle and Dietary Changes Three things you can do, in addition to treatment, that will help improve your symptoms and improve your health in general are: Eating a healthy, well-balanced diet Regular exercise Avoiding or managing stress
When exploring semaglutide for weight loss, both oral and injectable forms are available